Recent research highlights a novel approach for retinoblastoma treatment using lipid nanoparticles to co-deliver human RB1 mRNA and triptolide. This localized genetic therapy aims to enhance therapeutic efficacy against this aggressive childhood cancer.
lipid nanoparticle mediated co delivery of human rb1 mrna and triptolide for localized genetic therapy of retinoblastoma
Original title: “Lipid nanoparticle-mediated co-delivery of human RB1 mRNA and triptolide for localized genetic therapy of retinoblastoma.”